The Automated Infusion Systems Market is expanding as healthcare providers look for safer and more precise ways to deliver medications and fluids. The market was valued at USD 3.6 billion in 2024 and is projected to reach USD 6.5 billion by 2035, growing at a 5.4% CAGR during 2026–2035.
Technology is transforming infusion systems through AI, IoT, wireless connectivity, and advanced monitoring capabilities. Smart devices can support more accurate dosing, real-time data access, and better workflow management, making connected infusion technology increasingly relevant in modern healthcare settings.
Smart infusion pumps are expected to remain an important product category, alongside syringe pumps, volumetric pumps, and patient-controlled analgesia pumps. Applications span chemotherapy, anesthesia, pain management, diabetes care, and nutrition therapy, giving manufacturers opportunities across multiple clinical areas.
Hospitals account for a major share of demand, while home care, ambulatory surgery centers, and specialty clinics are also adopting automated solutions. North America leads the market, supported by advanced healthcare infrastructure, while Asia-Pacific offers strong potential as healthcare investment and access to medical technologies increase.
Future growth opportunities are emerging through EHR integration, telehealth connectivity, remote monitoring, and AI-powered predictive analytics. More user-friendly systems designed for home healthcare could further expand adoption as treatment increasingly moves beyond traditional hospital environments.
